Immunomodulatory treatment of relapsing-remitting multiple sclerosis - the ASSET (Avonex Assessment in Multiple Sclerosis Therapy) study, an observational study in 1354 patients
机构:
UT Southwestern Med Ctr Dallas, Dept Neurol & Neurotherapeut, Dallas, TX USA
VA North Texas Hlth Care Syst, Neurol Sect, Med Serv, Dallas, TX USAUniv Dusseldorf, Dept Neurol, Dusseldorf, Germany